Evidence map›Paper›PMID 26133762›Full record

ArticleMolecules (Basel, Switzerland)2015

Induction of Mitochondrial Dependent Apoptosis in Human Leukemia K562 Cells by Meconopsis integrifolia: A Species from Traditional Tibetan Medicine.

Jianping Fan, Pan Wang, Xiaobing Wang, Wei Tang, Chunliang Liu, Yaqin Wang, Wenjuan Yuan, Lulu Kong, Quanhong Liu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jianping FanCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. qhfanjianping@126.com.
Pan WangCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. wangpan@snnu.edu.cn.
Xiaobing WangCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. wangxiaobing@snnu.edu.cn.
Wei TangCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. tangwei@snnu.edu.cn.
Chunliang LiuCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. 41208166@snnu.edu.cn.
Yaqin WangCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. wangyaqinjilin@snnu.edu.cn.
Wenjuan YuanCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. yuanwenjuan@snnu.edu.dn.
Lulu KongCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. konglulu@snnu.edu.cn.
Quanhong LiuCo-Innovation Center for Qinba Regions' Sustainable Development, College of Life Sciences, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, 710119 Xi'an, China. lshaof@snnu.edu.cn.
Shaanxi Normal University · CNChang'an University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMeconopsis integrifolia (M. integrifolia) is one of the most popular members in Traditional Tibetan Medicine. This study aimed to investigate the anticancer effect of M. integrifolia and to detect the underlying mechanisms of these effects.

methods3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and trypan blue assay were used to evaluate the cytotoxicity of M. integrifolia. Changes in cell nuclear morphology and reactive oxygen species (ROS) level were observed by fluorescent microscopy. Apoptosis ratio, DNA damage and mitochondrial membrane potential (MMP) loss were analyzed by flow cytometry. Western blotting assay was adopted to detect the proteins related to apoptosis. Immunofluorescence was used to observe the release of cytochrome C.

resultsThe obtained data revealed that M. integrifolia could significantly inhibit K562 cell viability, mainly by targeting apoptosis induction and cell cycle arrest in G2/M phase. Collapse in cell morphology, chromatin condensation, DNA damage and ROS accumulation were observed. Further mechanism detection revealed that mitochondrion might be a key factor in M. integrifolia-induced apoptosis.

conclusionsM. integrifolia could induce mitochondria mediated apoptosis and cell cycle arrest in G2/M phase with little damage to normal cells, suggesting that M. integrifolia might be a potential and efficient anticancer agent that deserves further investigation.

Indexed as

Medicine, TraditionalApoptosisHumansK562 CellsLeukemiaMembrane Potential, MitochondrialMitochondriaReactive Oxygen SpeciesTibetReactive Oxygen SpeciesapoptosisG2/M phase arrestK562 cellsM. integrifolia ethanol extractmitochondria

Identifiers

PMID26133762
PMCPMC6332253
OpenAlexW1649297410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.